Navigation Links
Amylin Pharmaceuticals Reports Third Quarter Financial Results
Date:10/19/2011

SAN DIEGO, Oct. 19, 2011 /PRNewswire/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today reported financial results for the quarter ended September 30, 2011.

  • Total revenue was $175.0 million, which included net product sales of $155.1 million and a $15.0 million milestone payment from Eli Lilly and Company in connection with the launch of BYDUREON in the European Union
  • Non-GAAP operating income was $13.0 million, compared to a non-GAAP operating loss of $16.1 million for the same period in 2010
  • GAAP net loss was $13.2 million, or $0.09 per share, compared to $50.7 million, or $0.35 per share, for the same period in 2010
  • Cash, cash equivalents, short-term investments and restricted cash totaled $460.8 million at the end of the quarter

  • "We continue to advance our goal of bringing the first ever once-weekly diabetes therapy to patients in the U.S. We are closely monitoring BYDUREON launches across Europe and will apply insights from those launches to our U.S. planning for this important therapy," said Daniel M. Bradbury, president and chief executive officer of Amylin Pharmaceuticals. "Additionally, we look forward to the FDA's anticipated decision on an expanded label for BYETTA for use with insulin glargine. We believe this complementary approach to glycemic control will be a smart partnership that could result in an important new treatment option for patients. We continue our focus on fiscal discipline as we execute against our strategic objectives through the end of the year, and plan for the pivotal year ahead."  

    Highlights of Amylin's Third Quarter and Recent ActivitiesBYDUREON

  • Submitted a reply to a complete response letter by the U.S. Food and Drug Administration (FDA) regarding BYDUREON™ (exenatide extended-release for injectable suspension), which included results from a thorough QT study that
    '/>"/>

  • SOURCE Amylin Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Amylin Pharmaceuticals to Webcast Third Quarter Results
    2. Amylin Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
    3. Amylin and Takeda Discontinue Development of Pramlintide/Metreleptin Combination Treatment for Obesity Following Commercial Reassessment of the Program
    4. Amylin Pharmaceuticals to Webcast Second Quarter Results
    5. U.S. District Court Rules in Favor of Lilly in Amylin Litigation
    6. Amylin Pharmaceuticals Issues Statement Regarding U.S. District Court Order
    7. Amylin Pharmaceuticals Obtains Temporary Restraining Order Against Eli Lilly
    8. Lilly Comments on Court Ruling in Amylin Litigation
    9. Amylin Pharmaceuticals to Present at Annual Meeting of Stockholders
    10. Lilly Provides Its Perspective in Response to Amylin Lawsuit
    11. Lilly Provides Statement in Response to Amylin Lawsuit
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/14/2014)... 14, 2014  GenSpera, Inc. (OTCQB: GNSZ), a ... of cancer, announces that Kareg Corporation,s Director of ... the following research report on  the company. ... of Research, Kareg Corporation, Initiating Coverage with a ... full report: http://www.genspera.com/press/140711_Genspera_research_report_July2014.pdf GNSZ ...
    (Date:7/14/2014)... 2014  Otonomy, Inc., a clinical-stage biopharmaceutical company focused ... diseases and disorders of the inner and middle ear, ... statement on Form S-1 with the U.S. Securities and ... offering of shares of its common stock. All shares ... will be offered by Otonomy. The number of shares ...
    (Date:7/14/2014)... and LONDON , July 14, 2014 ... IXICO plc (AIM: IXI) jointly announced today the formation ... companies. Dr. Edward Ashton , Ph.D., chief scientific ... have seven members. "The formation of this ... the international commercial and operational alliance we signed with ...
    Breaking Medicine Technology:Kareg Corporation Initiates Coverage on GenSpera with a Speculative Buy Recommendation 2Kareg Corporation Initiates Coverage on GenSpera with a Speculative Buy Recommendation 3Kareg Corporation Initiates Coverage on GenSpera with a Speculative Buy Recommendation 4Kareg Corporation Initiates Coverage on GenSpera with a Speculative Buy Recommendation 5Kareg Corporation Initiates Coverage on GenSpera with a Speculative Buy Recommendation 6Otonomy Files Registration Statement for Proposed Initial Public Offering 2VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 2VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 3VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 4VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 5VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 6VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 7VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 8VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 9
    ... YORK, Sept. 21 An eminent international panel of ... LLY ) to receive a World Business and ... successful partnerships in the battle against multidrug-resistant tuberculosis (MDR-TB). ... of The Lilly MDR-TB Partnership demonstrate a clear linkage ...
    ... According to Millennium Research Group (MRG), the global authority ... new growth factors, combined with greater variety and improved features ... market to nearly $2.3 billion through 2015. Medtronic ... AMPLIFY , is set to be released in the US ...
    Cached Medicine Technology:Lilly Recognized with World Business and Development Award for Tuberculosis Initiative 2Lilly Recognized with World Business and Development Award for Tuberculosis Initiative 3Introduction of New Products and Increased Uptake of Innovative Materials to Drive US Bone Graft Substitute Market to Nearly $2.3 Billion by 2015 2Introduction of New Products and Increased Uptake of Innovative Materials to Drive US Bone Graft Substitute Market to Nearly $2.3 Billion by 2015 3
    (Date:7/14/2014)... Laurel, N.J. (PRWEB) July 14, 2014 ... Mount Laurel, has announced the publication of its first military ... plane crash on Black Thursday in October 1943 and 19 ... March to return home and build the American dream. ... II and the American dream (Amazon) is a ...
    (Date:7/14/2014)... According to a recent study ... a connection between women with high levels of a ... doctors have theorized about the role stress plays in ... provide scientific support. , “Stress, if very significant, can ... Barmat, an OB/GYN who specializes in reproductive endocrinology and ...
    (Date:7/14/2014)... There’s an old adage that says first impressions make ... say the products offered in their preorder event not only ... The Lash Palette for $40,” said Jenelle Paris, founder and ... explained that the first 1,000 have already been sold during ... on to point out that her company is an online ...
    (Date:7/14/2014)... Jordan Valley Medical Center is expanding the ... center set to open by the fall of 2015. ... west of I-15 in the Salt Lake Valley providing ... Valley Medical Center has partnered with Elekta, a company ... for radiation therapy, radiosurgery and brachytherapy, to bring Versa ...
    (Date:7/14/2014)... For the Spanish Royal Academy, senescent is he who ... the dictionary: not only is senescence not a synonym ... the organism. Cellular senescence is such a badly named ... area think it needs another name. That is the ... Research Centre (CNIO), one of the world,s leading experts ...
    Breaking Medicine News(10 mins):Health News:Mount Laurel-based Documented Legacy to Release Military Memoir of World War II Air Force Vet Who Survived Black Thursday Crash 2Health News:Abington Health Physician Addresses Link Between Stress and Infertility 2Health News:Abington Health Physician Addresses Link Between Stress and Infertility 3Health News:The Lash Palette Preorder Event Has Officially Begun 2Health News:Jordan Valley Medical Center Set to Break Ground with New $10 Million Cancer Center 2Health News:Manuel Serrano proposes a new vision of a process wrongly associated with ageing 2Health News:Manuel Serrano proposes a new vision of a process wrongly associated with ageing 3
    ... diabetes research in India, even though the country remains one ... disease. Indian scientists have published only one percent of the ... Indian Journal of Medical Research, in an assessment of the ... India published a total of 3068 papers during the 30 ...
    ... 25 million dollar space programme, will carry out scientific ... cells in outer space, reports said Wednesday. ... and the crystallisation of protein, said Abdul Rahman Abdul ... National University of Malaysia. ,"The research is ...
    ... their health by using over the counter nutritional supplements ... cons with the health professionals managing their conventional treatment. ... Griffith's School of Nursing, says that though some complementary ... have side effects or interact with conventional medications. ...
    ... School of Medicine in St. Louis, Missouri, have found ... to treatments for deadliest poisons like Ricin, cholera toxin, ... deadly strains of E. coli bacteria, these toxins travel ... Golgi network and endoplasmic reticulum before interrupting protein synthesis. ...
    ... a developing female sheep foetus to low doses of commonly ... ,The study was conducted by a team ... of Aberdeen, Scotland, UK. ,As part of the ... a cocktail of chemicals and heavy metals in an animal ...
    ... New research by the British charity Save the Children, shows ... nutritious diet , they would have to spend three times ... reported by The Independent, this would amount to a 1,700 ... research calculated how much a healthy diet, based on local ...
    Cached Medicine News:Health News:India's Share in Global Diabetes Research is One Percent 2Health News:Diabetics Risking Health by Using Alternative Medications Without Consultation 2Health News:For Bangladeshis, a Nutritious Diet Would Cost 1,700 Pounds Per Week 2
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    Medicine Products: